Effective Date: July 29, 2026
Welcome to the website of Cure LGMD2i Canada Foundation (“Cure LGMD2i Canada,” “we,” “our,” or “us”). By accessing or using our website, curelgmd2icanada.org, you agree to these Terms of Use. If you do not agree with these terms, please do not use our website.
1. About Cure LGMD2i Canada Foundation
Cure LGMD2i Canada Foundation is a federally incorporated not-for-profit organization in Canada dedicated to advancing awareness, advocacy, education, community support, and research related to Limb-Girdle Muscular Dystrophy Type 2i/R9 (LGMD2i/R9).
Our website provides information about our organization, programs, events, advocacy efforts, educational resources, and opportunities to connect with the LGMD2i/R9 and broader neuromuscular community.
2. Website Information
The information provided on this website is intended for general educational and informational purposes only.
While we make every effort to ensure that information on our website is accurate and current, Cure LGMD2i Canada Foundation does not guarantee that all information is complete, accurate, or free from errors.
Information provided on this website should not be considered medical advice, diagnosis, or treatment recommendations. Individuals should consult qualified healthcare professionals regarding medical questions, treatment decisions, or personal health concerns.
3. Use of Our Website
You agree to use this website only for lawful purposes and in a way that does not harm, restrict, or interfere with the use of the website by others.
You may:
- Access and view information for personal, educational, and non-commercial purposes.
- Share links to our website and publicly available resources.
You may not:
- Copy, modify, distribute, or reproduce website content for commercial purposes without written permission.
- Use our website or content in a way that misrepresents Cure LGMD2i Canada Foundation.
- Attempt to interfere with website security, functionality, or availability.
4. Intellectual Property
All content on this website, including text, graphics, logos, images, documents, and other materials, is owned by or licensed to Cure LGMD2i Canada Foundation unless otherwise stated.
Our name, branding, logos, and original materials may not be used without prior written permission.
5. External Links
Our website may include links to external websites, organizations, research resources, conferences, or community partners.
These links are provided for informational purposes and convenience. Cure LGMD2i Canada Foundation does not control or endorse all external websites and is not responsible for their content, privacy practices, or availability.
We encourage visitors to review the terms and privacy policies of any external websites they visit.
6. Donations and Support
Information regarding donations, fundraising initiatives, and community events is provided for informational purposes.
Cure LGMD2i Canada Foundation reserves the right to update, modify, or discontinue fundraising initiatives, events, or programs at any time.
7. Privacy
Your privacy is important to us. Information collected through our website is handled in accordance with our Privacy Policy.
Please review our Privacy Policy for more information about how we collect, use, and protect personal information.
8. Website Availability
We strive to keep our website available and functioning properly; however, we cannot guarantee uninterrupted access or that the website will always be free from technical issues.
We reserve the right to update, modify, or temporarily suspend any portion of our website without notice.
9. Changes to These Terms
Cure LGMD2i Canada Foundation may update these Terms of Use from time to time to reflect changes to our website, programs, or legal requirements.
The updated version will be posted on this page with the revised effective date.
10. Contact Us
If you have questions regarding these Terms of Use, please contact:
Cure LGMD2i Canada Foundation
Calgary, Alberta, Canada
Email: [email protected]
Thank you for visiting Cure LGMD2i Canada Foundation and supporting our mission to improve awareness, advocacy, education, and research for individuals and families affected by LGMD2i/R9.
